Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elisabeth, Mocaër"'
Autor:
Saïd M’Dahoma, Matthieu Poitevin, Eric Dabala, Hugo Payan, Cecilia Gabriel, Elisabeth Mocaër, Sylvie Bourgoin, Michel Hamon
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Previous data showed that neuropathic pain induced by mechanical lesion of peripheral nerves has specific characteristics and responds differently to alleviating drugs at cephalic versus extracephalic level. This is especially true for tricyclic anti
Externí odkaz:
https://doaj.org/article/ca87b394235e46ca9ae7f97eeaedc7d7
Autor:
Saïd, M'Dahoma, Matthieu, Poitevin, Eric, Dabala, Hugo, Payan, Cecilia, Gabriel, Elisabeth, Mocaër, Sylvie, Bourgoin, Michel, Hamon
Publikováno v:
Frontiers in pharmacology. 9
Previous data showed that neuropathic pain induced by mechanical lesion of peripheral nerves has specific characteristics and responds differently to alleviating drugs at cephalic versus extracephalic level. This is especially true for tricyclic anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2454dd36b5c29dd63028e87f332db8df
https://pubmed.ncbi.nlm.nih.gov/29930510
https://pubmed.ncbi.nlm.nih.gov/29930510
Autor:
Marc Richelle, Jean Claude Poignant, Isabelle Hermans, Marie-Claire Rettori, Helga Lejeune, Elisabeth Mocaër
Publikováno v:
Pharmacology Biochemistry and Behavior. 51:165-173
Experiment 1 recorded the effects of single (doses of 1, 5, 10, and 20 mg/kg) and repeated intraperitoneal injections (10 mg/kg) of amineptine (a tricyclic antidepressant drug) on the performance of albino rats in differential reinforcement of low ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28dd216a31fb8ca5e2edd5c774ebfc15
https://doi.org/10.1016/0091-3057(94)00371-o
https://doi.org/10.1016/0091-3057(94)00371-o
Publikováno v:
Drug Development Research. 32:183-190
Previous studies have shown that (±) S 20244 (8-(4-[N-(5-methoxychroman-3-yl)N-propylamino] butyl) 8-azaspiro[4,5]decane-7,9 dione) and its isomers (+) S 20499 and (−) S 20500 are full agonists at 5-HT1A receptors. In the present study, the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b29c21d1f16256e2edfb305d24e29f8d
https://doi.org/10.1002/ddr.430320308
https://doi.org/10.1002/ddr.430320308
Autor:
Girstaute, Dagyte, Andrea, Trentani, Folkert, Postema, Paul G, Luiten, Johan A, Den Boer, Cecilia, Gabriel, Elisabeth, Mocaër, Peter, Meerlo, Eddy A, Van der Zee
Publikováno v:
CNS neurosciencetherapeutics. 16(4)
Agomelatine is a novel antidepressant which acts as a melatonergic (MT1/MT2) receptor agonist and serotonergic (5‐HT(2C)) receptor antagonist. The antidepressant properties of agomelatine have been demonstrated in animal models as well as in clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f631973b2a945b42d5a592ac70b25d0
https://pubmed.ncbi.nlm.nih.gov/20236141
https://pubmed.ncbi.nlm.nih.gov/20236141
Autor:
Antoine Lenègre, Roger D. Porsolt, Elisabeth Mocaër, Daniel H. Caignard, Bruno Pfeiffer, Beatrice Guardiola-Lemaitre
Publikováno v:
Drug Development Research. 27:389-402
S 20499 is the (+) enantiomer of the racemic compound S 20244 (4-N-(methoxychromane-3-yl) N-propylamino butyl-8-azaspiro 4,5 decane-7,9 dione), a novel 5-hydroxytryptamine1A (5-HT1A) agonist. The present experiments examined the potential anxiolytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cab7f0086aa57d4a09e02971c5576a86
https://doi.org/10.1002/ddr.430270407
https://doi.org/10.1002/ddr.430270407
Autor:
Francis Kiniffo, Elisabeth Mocaër, Mathieu Molimard, Marie Blanc, Charles Advenier, Emmanuel Naline
Publikováno v:
Drug Development Research. 26:147-156
The effects of S 9977-2, a new compound which belongs to the trimethylxanthine family and has shown in vivo promnesic activity and in vitro acetylcholinesterase activities inhibition, were studied on the guinea pig isolated trachea and on human isola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77e0f1084744910f88b2aa92f69c0405
https://doi.org/10.1002/ddr.430260204
https://doi.org/10.1002/ddr.430260204
Publikováno v:
Drug Development Research. 27:265-276
The effects of S 9977 (1,3,7-trimethyl 8-[3-(4-diethylaminocarbonyl-l-piperazinyl) 1-propyl]-3,7-dihydro(1H)2,6-purinedione hydrochloride) on the amnesias induced by scopolamine, diazepam, and electroconvulsive shock (ECS) were studied in a passive a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::054badf43d4da3a5adb403e38d83b88b
https://doi.org/10.1002/ddr.430270306
https://doi.org/10.1002/ddr.430270306
Autor:
Mark J, Millan, Per, Svenningsson, Charles R, Ashby, Michael, Hill, Martin, Egeland, Anne, Dekeyne, Mauricette, Brocco, Benjamin, Di Cara, Françoise, Lejeune, Nitza, Thomasson, Carmen, Munoz, Elisabeth, Mocaër, Alan, Crossman, Laetitia, Cistarelli, Sylvie, Girardon, Loretta, Iob, Sylvie, Veiga, Alain, Gobert
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 324(2)
The novel benzopyranopyrrolidine, S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], is a preferential antagonist of cloned human D(3) versus D(2L) and D(2S) receptors. In mice, S33138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::158df601b15ada748f4dfe3606d13cc7
https://pubmed.ncbi.nlm.nih.gov/18024787
https://pubmed.ncbi.nlm.nih.gov/18024787
Publikováno v:
Behavioural pharmacology. 17(1)
The activity of the novel antidepressant agomelatine was evaluated in three models of anxiety and compared with that of melatonin and two anxiolytics, diazepam and buspirone. All drugs were tested 2 h before and 2 h after the dark phase of the diurna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f219ab2e97390c91f76f07e43cf45999
https://pubmed.ncbi.nlm.nih.gov/16377959
https://pubmed.ncbi.nlm.nih.gov/16377959